Advertisement
Screener

Processa Pharmaceuticals, Inc. (PCSA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Processa Pharmaceuticals, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Processa Pharmaceuticals, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $11.39M went out.
  • Fiscal year ended 2025-12-31: from investing, $850.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $16.58M came in.
  • Fiscal year ended 2025-12-31: change in cash, $4.35M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDividendsDebt paid backStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31-$11.39M-$850.00K-$10.40K$16.60M$4.35M
2024-12-31-$11.25M-$3.24K-$15.90K$7.76M-$3.51M
2023-12-31-$8.06M-$2.78K$6.32M-$1.80M
2022-12-31-$9.61M-$300.00K-$88.84K-$9.99M
2021-12-31-$8.72M-$64.40K$10.05M-$186.49K$1.08M
2020-12-31-$3.14M-$95.21K$17.10M$862.46K*$14.72M
2019-12-31-$2.75M$1.70M*-$1.05M
2018-12-31-$3.71M-$22.28K$2.87M-$168.46K-$1.11M
2017-12-31-$1.65M$1.00M$2.43M*$1.78M
2016-12-31-$2.16M-$1.04M$4.27M$1.07M
2015-12-31-$871.91K$40.20K-$19.90K$88.00K$753.00K*-$10.60K
2014-12-31-$2.69M-$44.94K-$45.59K-$45.53K$366.32K$2.30M*-$161.82K
2013-12-31-$2.54M-$27.67K-$30.24K$1.76M*-$834.61K
2012-12-31-$1.89M-$334.34K-$8.91K$300.00K-$1.77M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30-$2.00M*$186.00K*$0.00*$315.17K*
2026-03-31-$3.59M-$500.00K-$320.00$245.10K-$3.85M
2025-12-31-$2.90M*$0.00*$2.98M*
2025-09-30-$3.48M*$0.00*$2.86M*
2025-06-30-$2.27M*-$8.96K*$6.32M*
2025-03-31-$2.73M-$1.44K$4.44M$1.71M
2024-12-31-$2.25M*$0.00*-$312.00*$549.36K*
2024-09-30-$3.60M*-$3.66K*$931.29K*
2024-06-30-$3.35M*-$2.01K*$0.00*
2024-03-31-$2.05M-$9.92K$6.28M$4.21M
2023-12-31-$2.12M*$0.00*-$30.61K*
2023-09-30-$1.76M*$0.00*
2023-06-30-$2.06M*$0.00*
2023-03-31-$2.11M$6.35M$4.24M
2022-12-31-$2.50M*$0.00*-$53.60K*$6.44M*
2022-09-30-$2.97M*$0.00*
2022-06-30-$2.33M*$0.00*
2022-03-31-$1.80M-$300.00K-$2.10M
2021-12-31-$2.73M*-$36.42K*-$6.21K*
2021-09-30-$1.55M*-$157.20K*
2021-06-30-$2.19M*
2021-03-31-$2.24M$9.88M*$7.63M
2020-12-31-$2.28M*$17.37M*
2020-09-30$29.19K*-$356.42K*
2020-06-30-$350.58K*$660.95K*
2020-03-31-$546.45K-$549.26K
2019-12-31-$613.49K*$800.72K*
2019-09-30-$721.76K*$504.07K*
2019-06-30-$807.47K*
2019-03-31-$607.43K-$492.43K
2018-12-31-$463.98K*$0.00*-$90.41K*-$51.12K*-$683.26K*
2018-09-30-$1.01M*$475.50K*$109.02K*$0.00*-$426.23K*
2018-06-30-$1.16M*-$496.00K*$1.07M*
2018-03-31-$1.07M-$1.78K-$1.07M
2017-12-31-$675.79K*-$14.34K*$2.50M*$1.81M*
2017-09-30-$622.89K*$1.02M*$322.28K*
2017-06-30-$297.23K*$0.00*-$297.23K*
2017-03-31-$58.70K-$882.00-$59.58K
2016-12-31-$2.12M*-$1.06M*$4.25M*$1.08M*
2016-09-30$16.74K*-$25.00K*-$8.26K*
2016-06-30-$2.57K*$15.00K*$12.43K*
2016-03-31-$50.37K$27.00K-$8.37K
2015-12-31-$46.07K*$41.60K*$0.00*$0.00*-$4.47K*
2015-09-30-$47.23K*$0.00*$8.13K*$0.00*-$96.00*
2015-06-30-$276.52K*-$2.80K*-$14.07K*$0.00*-$26.59K*
2015-03-31-$502.09K$1.40K-$13.96K$88.00K$20.55K
2014-12-31-$455.57K*-$22.58K*-$13.86K*-$30.69K*
2014-09-30-$540.24K*-$9.95K*-$12.98K*$579.00K*$15.84K*
2014-06-30-$708.09K*-$2.00K*-$8.23K*$675.97K*-$42.35K*
2014-03-31-$987.74K-$10.42K-$10.46K$0.00*$0.00*$904.00K*-$104.62K
2013-12-31-$462.54K*-$1.00*-$9.89K*$0.00*-$809.07K*
2013-09-30-$709.32K*-$20.34K*-$6.83K*$0.00*$1.11M*$372.13K*
2013-06-30-$773.93K*-$1.06K*-$6.78K*$990.09K*$208.31K*
2013-03-31-$592.97K-$6.28K-$6.74K-$605.99K
2012-12-31-$647.83K*-$14.38K*-$370.84K*
2012-09-30-$656.25K*-$244.27K*-$738.51K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Pulmatrix, Inc. (PULM)United States$0.006B
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59